Paper - WANFANG MED ONLINE

You Position: Home > Paper

Relationship between non-alcoholic fatty liver disease and cardiovascular disease

( views:23, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 9

DOI:: 10.11569/wcjd.v28.i9.313

Key Word:: 非酒精性脂肪性肝病;动脉粥样硬化;冠心病;高血压;发病机制

Abstract：随着非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的深入研究,近几年来发现与心血管疾病(cardiovascular disease,CVD)密切相关.现已证明,NAFLD是CVD发生的重要危险因素,也是年青人动脉硬化、冠心病、高血压发病的重要机制.本文就NAFLD对动脉粥样硬化和CVD的影响、发病机制进行综述,以提高肝病和CVD医师的认识水平,为做好防治提供资源.

Reference

[1]SUN Ling,L(U) Shu-zheng.Association between non-alcoholic fatty liver disease and coronary artery disease severity[J].2011,(6).
[2]Sao, Rahul,Aronow, Wilbert S..Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.[J].2018,14(6).
[3]Nilanka Perera,Jegarajah Indrakumar,Waruni Vijitha Abeysinghe,etc.Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka[J].2016,(1).
[4]Bartz,T.M.,Mukamal,K.J.,Rimm,E.B.,etc.Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: The cardiovascular health study[J].2013,36(5).
[5]Antonio,Nouvenne,Andrea,Ticinesi,Claudio,Tana,etc.Digestive disorders and Intestinal microbiota.[J].2018,89(9-S).
[6]Petra Louis,Harry J. Flint.Formation of propionate and butyrate by the human colonic microbiota[J].2016,19(1).
[7]Fargion, Silvia,Porzio, Marianna,Fracanzani, Anna Ludovica.Nonalcoholic fatty liver disease and vascular disease: State-of-the-art[J].2014,20(37).
[8]Ekstedt, Mattias,Hagstrom, Hannes,Nasr, Patrik,etc.Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up[J].2015,61(5).
[9]Niranjana, Natarajan,Daijiro, Hori,Sheila, Flavahan,etc.Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41.[J].2016,(Spec ).
[10]Giulia, Chinetti-Gbaguidi,Morgane, Baron,Mohamed Amine, Bouhlel,etc.Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.[J].2011,108(8).
[11]P, Loria,G, Marchesini,F, Nascimbeni,etc.Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.[J].2014,232(1).
[12]Dan L, Dumitrascu,Manuela G, Neuman.Non-alcoholic fatty liver disease: an update on diagnosis.[J].2018,91(2).
[13]Baragetti, A.,Pisano, G.,Bertelli, C.,etc.Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population[J].2016,26(2).
[14]Manik Lal Thakur,Sanjay Sharma,Atin Kumar,etc.Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indian[J].2012,223(2).
[15]Miyamoto, Junki,Kasubuchi, Mayu,Nakajima, Akira,etc.The role of short-chain fatty acid on blood pressure regulation[J].2016,25(5).
[16]Zheng, Yan,Li, Yanping,Rimm, Eric B.,etc.Dietary phosphatidylcholine and risk of all-cause and cardiovascular-specific mortality among US women and men[J].2016,104(1).
[17]Pareé, Guillaume,Ridker, Paul M,Rose, Lynda,etc.Genome-Wide Association Analysis of Soluble ICAM-1 Concentration Reveals Novel Associations at the NFKBIK, PNPLA3, RELA, and SH2B3 Loci.[J].2011,7(4).
[18]Petta, Salvatore,Dongiovanni, Paola,Gulino, Alessandro,etc.MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease[J].2016,64(3).
[19]Miao, Ji,Ling, Alisha V.,Manthena, Praveen V.,etc.Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis[J].2015,6(Apr.).
[20]Kim, Min Kyung,Ahn, Chul Woo,Nam, Ji Sun,etc.Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women[J].2015,22(12).
[21]Gaetano, Zizzo,Philip L, Cohen.The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization.[J].2015,12.
[22]Nicholette D, Palmer,Solomon K, Musani,Laura M, Yerges-Armstrong,etc.Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.[J].2013,58(3).
[23]Zhu, Weifei,Gregory, Jill C.,Org, Elin,etc.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[J].2016,165(1).
[24]Kimberley, Lau,Varun, Srivatsav,Ayesha, Rizwan,etc.Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases.[J].2017,9(8).
[25]Mahmoud, Al Rifai,Michael G, Silverman,Khurram, Nasir,etc.The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).[J].2015,239(2).
[26]Luisa, Vonghia,Thea, Magrone,An, Verrijken,etc.Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features.[J].2015,10(11).
[27]Alessandro, Mantovani.NAFLD and risk of cardiac arrhythmias: Is hyperuricemia a neglected pathogenic mechanism?[J].2018,(Spec ).
[28]Santisteban, Monica M.,Qi, Yanfei,Zubcevic, Jasenka,etc.Hypertension-Linked Pathophysiological Alterations in the Gut[J].2017,120(2).
[29]Yoosoo,Chang,Seungho,Ryu,Ki-Chul,Sung,etc.Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.[J].2018.
[30]Brunt,E.M.,Kleiner,D.E..Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research[J].2012,32(1).
[31]Ioan,Sporea,Alina,Popescu,Dan,Dumitra?cu,etc.Nonalcoholic Fatty Liver Disease: Status Quo.[J].2018,27(4).
[32]Naim Alkhouri,Tarek Abu-Rajab Tamimi,Lisa Yerian,etc.The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk[J].2009,55(9).
[33]Lokpal Bhatia,Eleonora Scorletti,Nicholas Curzen,etc.Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression[J].2016.
[34]Li,Y.,Dalli,J.,Chiang,N.,etc.Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators[J].2013,39(5).
[35]Yang, Tao,Santisteban, Monica M.,Rodriguez, Vermali,etc.Gut Dysbiosis Is Linked to Hypertension[J].2015,65(6).
[36]Athanasia Skoura,Jason Michaud,Dong-Soon Im,etc.Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and Atherosclerosis[J].2010,31(1).
[37]Sven Francque,Sandrine Caron,Peter Michielsen,etc.Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.[J].2014,59(1).
[38]Chung, Goh Eun,Choi, Su-Yeon,Kim, Donghee,etc.Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index[J].2015,94(12).
[39]Oddgeir L Holmen,He Zhang,Yanbo Fan,etc.Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.[J].2014,46(4).
[40].Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke.[J].2017,12(2).
[41]Zeneng Wang,Elizabeth Klipfell,Brian J. Bennett,etc.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].2011,472(Apr.7 TN.7341).
[42]Saposnik G,Leung A,Ying I,etc.Nonalcoholic fatty liver disease and acute ischemic stroke.[J].2011,22(1).
[43]Koh, Ara,De Vadder, Filipe,Kovatcheva-Datchary, Petia,etc.From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites[J].2016,165(6).
[44]Yun Soo,Bae.Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.[J].2009,104.
[45]Ahmet Taha, Alper,Hakan, Hasdemir,Sinan, Sahin,etc.The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.[J].2008,36(6).
[46]Xu J,Sui Y,Zhou C,etc.Deficiency of PXR decreases atherosclerosis in apoE-deficient mice.[J].2011,52(9).
[47]Ji Hoon, Kang,Kyoung Im, Cho,Seong Man, Kim,etc.Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients.[J].2012,20(3).
[48]Didem, O?uz,Hakan ümit, ünal,Hacer, Ero?lu,etc.Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease.[J].2016,(12).
[49]Luminita, Latea,Stefania, Negrea,Sorana, Bolboaca.Primary non-alcoholic fatty liver disease in hypertensive patients.[J].2013,6(6).
[50]Musso, Giovanni,Cassader, Maurizio,De Michieli, Franco,etc.MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat[J].2017,26(9).
[51]Lisa B, VanWagner,Hongyan, Ning,Cora E, Lewis,etc.Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.[J].2014,235(2).
[52].Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.[J].2016,(9).
[53]Min-Kyung, Lee,Hye-Jeong, Park,Won Seon, Jeon,etc.Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study.[J].2015,14.
[54]Tilg H,Moschen AR.Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.[J].2010,52(5).
[55]Kasahara, Kazuyuki,Tanoue, Takeshi,Yamashita, Tomoya,etc.Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis[J].2017,58(3).
[56]Xin-yan YU,Yi ZHAO,Xiao-xiao SONG,etc.非肥胖、高血压和糖尿病的中国中青年人群中非酒精性脂肪性肝病和动脉硬度的关系研究[J].2014,(10).
[57]Wei-Yang, Chen,Min, Wang,Jingwen, Zhang,etc.Acrolein Disrupts Tight Junction Proteins and Causes Endoplasmic Reticulum Stress-Mediated Epithelial Cell Death Leading to Intestinal Barrier Dysfunction and Permeability.[J].2017,187(12).
[58]J Mark, Brown,Stanley L, Hazen.Microbial modulation of cardiovascular disease.[J].2018,(Spec ).
[59]Joyce, Susan A.,Gahan, Cormac G. M..Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota[J].2017,35(3).
[60]Kamila, Wójcik-Cichy,Ewa, Ko?lińska-Berkan,Anna, Piekarska.The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases.[J].2018,4(1).
[61]Zeneng Wang,W H Wilson Tang,Jennifer A Buffa,etc.Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.[J].2014,35(14).
[62]Junli,Ma,Houkai,Li.The Role of Gut Microbiota in Atherosclerosis and Hypertension.[J].2018,9.
[63]Troseid, M.,Ueland, T.,Hov, J. R.,etc.Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure[J].2015,277(6).
[64]Ragab A,Mahfouz,Mohammad,Gouda,Islam,Galal,etc.Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation.[J].2018.
[65]Li, Tiangang,Chiang, John Y. L..Bile acids as metabolic regulators[J].2015,31(2).
[66]Andrea,Ticinesi,Antonio,Nouvenne,Claudio,Tana,etc.The impact of intestinal microbiota on bio-medical research: definitions, techniques and physiology of a "new frontier".[J].2018,89(9-S).
[67]Yuji Matsuzawa,Tohru Funahashi,Shinji Kihara,etc.Adiponectin and Metabolic Syndrome[J].2003,24(1).
[68]Alessandro,Mantovani,Marco,Dauriz,Damiano,Sandri,etc.Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.[J].2019,39(4).
[69]Roszer,T.,Menéndez-Gutiérrez,M.P.,Cedenilla,M.,etc.Retinoid X receptors in macrophage biology[J].2013,24(9).
[70]Kui Zhang,Lushun Zhang,Bin Zhou,etc.Lack of association between TLR4 Asp299Gly polymorphism and atherosclerosis: evidence from meta-analysi[J].2012,130(4).
[71]"ORCID":"http:\/\/orcid.org\/0000-0002-6234-4955Marcello Ricardo Paulista Markus,Peter J. Meffert,Sebastian Edgar Baumeister,etc.Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population[J].2015,245.
[72]Aurelian Bidulescu,Lloyd E Chambless,Anna Maria Siega-Riz,etc.Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study[J].2007,7(1).
[73]Chen,Y.,Thadhani,R.,Szeto,F.L.,etc.Vitamin D receptor signaling inhibits atherosclerosis in Mice[J].2012,26(7).
[74]Kim, Byung Jin,Cheong, Eun Sun,Kang, Jung Gyu,etc.Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study[J].2016,10(3).
[75]Christina Guzzo,Amit Ayer,Sameh Basta,etc.IL-27 Enhances LPS-Induced Proinflammatory Cytokine Production via Upregulation of TLR4 Expression and Signaling in Human Monocytes[J].2011,188(2).
[76]Lee HR,Jung DH,Lee YJ,etc.Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification.[J].2010,48(12).
[77]Verhoef P,Bots ML,Olthof MR,etc.Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women.[J].2008,62(3).
[78]Koren, Omry,Spor, Aymé,Felin, Jenny,etc.Human oral, gut, and plaque microbiota in patients with atherosclerosis[J].2011,108(S1).
[79]Pluznick,Jennifer L..Renal and cardiovascular sensory receptors and blood pressure regulation.[J].2013,305(4).
[80].Clinical association between non-alcoholic fatty liver disease and the development of hypertension[J].2014,29(11).
[81]Julia Kozlitina,Eriks Smagris,Stefan Stender,etc.Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.[J].2014,46(4).
[82]Yilmaz Y,Kurt R,Yonal O,etc.Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.[J].2010,211(1).
[83]Kamo, Takehiro,Akazawa, Hiroshi,Suda, Wataru,etc.Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.[J].2017,12(3).
[84]Dongiovanni, Paola,Petta, Salvatore,Maglio, Cristina,etc.Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease[J].2015,61(2).
[85]Li, Xia,Shi, HuiRong,Wang, Zhuo,etc.Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease[J].2017,35(6).
[86]Cani PD,Amar J,Iglesias MA,etc.Metabolic endotoxemia initiates obesity and insulin resistance.[J].2007,56(7).
[87]Pereira, Evelyn Nunes Goulart Da Silva,Silvares, Raquel Rangel,Flores, Edgar Eduardo Ilaquita,etc.Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.[J].2017,12(6).
[88]Rigamonti E,Chinetti-Gbaguidi G,Staels B.Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.[J].2008,28(6).
[89]Dana J. Philpott,Matthew T. Sorbara,Susan J. Roberston,etc.NOD proteins: regulators of inflammation in health and disease[J].2014,14(1).
[90]Marques, Francine Z.,Nelson, Erin,Chu, Po-Yin,etc.High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice[J].2017,135(10).
[91]Kaa Kaasapahy.Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilu and Bifidobacterium spp.[J].2000,78(1).
[92]El Kholy, Karim,Genco, Robert J.,Van Dyke, Thomas E..Oral infections and cardiovascular disease[J].2015,26(6).
[93]Cai, Bishuang,Tabas, Ira,Subramanian, Manikandan,etc.MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation[J].2016,113(23).
[94]Petta, Salvatore,Argano, Christiano,Colomba, Daniela,etc.Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease[J].2015,62(4).
[95]Shunsuke, Kanno,Hisanori, Nishio,Tamami, Tanaka,etc.Activation of an innate immune receptor, Nod1, accelerates atherogenesis in Apoe-/- mice.[J].2015,194.
[96]Mahmut, A?ikel,Sadik, Sunay,Mustafa, Koplay,etc.Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.[J].2009,9(4).
[97]Li, N.,Zhang, G. -W.,Zhang, J. -R.,etc.Non-alcoholic fatty liver disease is associated with progression of arterial stiffness[J].2015,25(2).
[98]Silvia, Sookoian,Carlos J, Pirola.Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.[J].2011,53(6).
[99]Hyun-Jin, Kim,Chae-Wan, Lim,Jae Hyuk, Lee,etc.Gender-based differences in the relationship between fatty liver disease and atherosclerosis.[J].1900,27.
[100]Fredrik H, Karlsson,Frida, F?k,Intawat, Nookaew,etc.Symptomatic atherosclerosis is associated with an altered gut metagenome.[J].2012,3.
[101]Wang,T.,Liu,Y.,Chen,Y.,etc.Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and Elderly Chinese[J].2012,32(9).
[102]Binnur, Pinarba?i,Kadir, Dem?r,Hüseyin, Oflaz,etc.Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease.[J].2012,23(6).
[103]Denuja, Karunakaran,Michele, Geoffrion,Lihui, Wei,etc.Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.[J].2016,(7).
[104]Ebenezer T, Oni,Arthur S, Agatston,Michael J, Blaha,etc.A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?[J].2013,230(2).
[105]Kinugawa K,Tedgui A,Mallat Z,etc.Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.[J].2008,28(8).
[106]Pauliina, Pisto,Merja, Santaniemi,Risto, Bloigu,etc.Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.[J].2014,4(3).
[107]Babak, Baharvand-Ahmadi,Khalil, Sharifi,Mehrdad, Namdari.Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease.[J].2016,(4).
[108]Maryam Zaare, Nahandi,Manouchehr, Khoshbaten,Elham, Ramazanzadeh,etc.Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis.[J].2014,7(1).
[109]Rey FE,Faith JJ,Bain J,etc.Dissecting the in vivo metabolic potential of two human gut acetogens.[J].2010,285(29).
[110]Haneen, Azzam,Stephen, Malnick.Non-alcoholic fatty liver disease - the heart of the matter.[J].2015,7(10).
[111]Kui, Chen,Xiaoqian, Zheng,Mingchen, Feng,etc.Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice.[J].2017,8(Spec ).
[112]Assy N,Farah,Djibre A.Presence of coronary plaques in patients with nonalcoholic fatty liver disease.[J].2010,254(2).
[113]M R, Chacón,J, Lozano-Bartolomé,M, Portero-Otín,etc.The gut mycobiome composition is linked to carotid atherosclerosis.[J].2017,(Spec ).
[114]Giovanni, DI Maira,Mirella, Pastore,Fabio, Marra.Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines.[J].2017,(Spec ).
[115]Yilei Ding,Savitha Subramanian,Vince N Montes,etc.Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice.[J].2012,32(7).
[116]Macavei, B.,Baban, A.,Dumitrascu, D. L..Psychological factors associated with NAFLD/NASH: a systematic review[J].2016,20(24).
[117].Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: A role for oxidized polyunsaturated fatty acids?[J].2013,97(1).
[118]Soderberg C,Stal P,Askling.Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.[J].2010,51(2).
[119]Annika Wahlstrom,Sama I. Sayin,Hanns-Ulrich Marschall,etc.Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism[J].2016,24(1).
[120]Xiaojiao, Zheng,Fengjie, Huang,Aihua, Zhao,etc.Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.[J].2017,15(1).